Key result
Epigenome-wide association studies (EWAS) over the past decade have been applied to analyze complex diseases, with ongoing research into their biological applications and clinical translation.
This article reviews the 10-year history, biological applications, clinical translation, and future directions of Epigenome-Wide Association Studies (EWAS).
EWAS applications in complex diseases advance research; leaves open clinical translation pending rigorous validation.
Epigenome-Wide Association Study In article number 2100727 by Yongshuai Jiang, and co-workers, the research process of Epigenome-wide association study (EWAS), its application in biology and clinical translation are discussed. It concludes by analyzing the current limitations and forecasting the future of EWAS. A decade has passed since EWAS was applied to analyze complex diseases. The cover is full of blessings for the 10th anniversary of EWAS and expresses the dedication of researchers.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2021) conducted a review in Complex diseases. Epigenome-wide association study (EWAS) was evaluated. Epigenome-wide association studies (EWAS) over the past decade have been applied to analyze complex diseases, with ongoing research into their biological applications and clinical translation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: